Concepedia

Million A. Tegenge

MA

14

Publications

421

Citations

12

H-Index

2013

Active since

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Eli Lilly (United States)

National Center for Toxicological Research

Million A. Tegenge is an author at Center for Biologics Evaluation and Research specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

2013–2024

14

Publications

14

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation

Colleen Kuemmel, Yuching Yang, Xinyuan Zhang et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 151 citations · Full text

A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents

Iftekhar Mahmood, Million A. Tegenge · The Journal of Clinical Pharmacology · 2018 · 46 citations

Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision‐making—A workshop summary

Daphney Jean, Kunal Naik, Lauren Milligan et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 35 citations · Full text

A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines

Million A. Tegenge, Robert J. Mitkus · Journal of Pharmacokinetics and Pharmacodynamics · 2013 · 25 citations · Full text

, , +7

Model‐Informed Drug Development: Steps Toward Harmonized Guidance

Scott Marshall, Malidi Ahamadi, Jenny Y. Chien et al. · Clinical Pharmacology & Therapeutics · 2023 · 24 citations · Full text

, , +15

Rows per page

1–5 of 14